NCT01614795 2018-12-11Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory SarcomaNational Cancer Institute (NCI)Phase 2 Completed46 enrolled 13 charts
NCT00668148 2018-07-17A Five-Tier, Open-Label Study of IMC-A12 in Advanced SarcomaEli Lilly and CompanyPhase 2 Completed113 enrolled 13 charts